1. Home
  2. XOMA vs BACQ Comparison

XOMA vs BACQ Comparison

Compare XOMA & BACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • BACQ
  • Stock Information
  • Founded
  • XOMA 1981
  • BACQ 2024
  • Country
  • XOMA United States
  • BACQ United States
  • Employees
  • XOMA N/A
  • BACQ N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • BACQ
  • Sector
  • XOMA Health Care
  • BACQ
  • Exchange
  • XOMA Nasdaq
  • BACQ NYSE
  • Market Cap
  • XOMA 355.6M
  • BACQ 333.2M
  • IPO Year
  • XOMA N/A
  • BACQ 2024
  • Fundamental
  • Price
  • XOMA $26.76
  • BACQ $9.89
  • Analyst Decision
  • XOMA Strong Buy
  • BACQ
  • Analyst Count
  • XOMA 2
  • BACQ 0
  • Target Price
  • XOMA $81.50
  • BACQ N/A
  • AVG Volume (30 Days)
  • XOMA 36.4K
  • BACQ 2.3K
  • Earning Date
  • XOMA 03-07-2025
  • BACQ 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • BACQ N/A
  • EPS Growth
  • XOMA N/A
  • BACQ N/A
  • EPS
  • XOMA N/A
  • BACQ N/A
  • Revenue
  • XOMA $21,606,000.00
  • BACQ N/A
  • Revenue This Year
  • XOMA $511.48
  • BACQ N/A
  • Revenue Next Year
  • XOMA $26.91
  • BACQ N/A
  • P/E Ratio
  • XOMA N/A
  • BACQ N/A
  • Revenue Growth
  • XOMA 389.82
  • BACQ N/A
  • 52 Week Low
  • XOMA $18.57
  • BACQ N/A
  • 52 Week High
  • XOMA $35.00
  • BACQ N/A
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 47.49
  • BACQ N/A
  • Support Level
  • XOMA $23.88
  • BACQ N/A
  • Resistance Level
  • XOMA $29.02
  • BACQ N/A
  • Average True Range (ATR)
  • XOMA 1.27
  • BACQ 0.00
  • MACD
  • XOMA 0.27
  • BACQ 0.00
  • Stochastic Oscillator
  • XOMA 56.03
  • BACQ 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About BACQ BLEICHROEDER ACQUISITION CORP. I

Bleichroeder Acquisition Corp I is a blank check company.

Share on Social Networks: